Frequently Asked Questions

The Implantable Collamer Lens for short-sightedness and astigmatism is a refractive lens also known as a phakic IOL. “Phakic” meaning that the natural lens of the eye is in place, and “IOL” meaning intraocular lens, or a lens inside the eye. The EVO ICL is a posterior chamber implant that is introduced through a small incision in the eye and is placed behind the iris (the coloured part of the eye), and in front of the natural crystalline lens in order to improve your short-sightedness and astigmatism.

The EVO ICL is designed for patients who are between 21 and 60 years old. Those who are short-sighted with mild to severe myopia (-0.5D to -20D). Patients who are long-sighted with mild to severe hyperopia (+0.5D to +10.0D. Those with an astigmatism between 0.5 and 6.0 D. Are looking for a procedure that doesn’t create dry eye syndrome

In order for your surgeon to get the most out of an EVO ICL for you, your eyesight should not have a change in prescription of more than .5D in a year.

Patients who are pregnant and nursing and patients with a narrow angle in the front chamber of their eye, because in this case the space for the EVO ICL lens would be too small. The patient education booklet provides an additional list of conditions that should be taken into consideration when making a decision about the EVO ICL procedure.

The key benefit of EVO ICL surgery is the permanent correction or reduction of your short-sightedness, long-sightedness or astigmatism allowing you to see clearly without eyeglasses or contact lenses or reduce your dependence upon them. In addition to the improvement of your uncorrected vision (vision without eyeglasses or contact lenses), your best corrected vision (best vision with contact lenses/eye glasses) may be improved.

Follow all of your eye care professional’s instructions before and after implantation of the EVO ICL lens. Take any prescribed medication and schedule all recommended follow-up visits with your eye care professional, usually on an annual basis after the healing of the surgery. Contact your eye care professional immediately if you should experience a problem.

The material is called Collamer® , a collagen co-polymer that contains a small amount of purified collagen which is proprietary to STAAR Surgical; the remainder is made of a similar material to that found in soft contact lenses. It is very biocompatible (does not cause a reaction inside the eye) and stable. It also contains an ultraviolet light filter.

Prior to being placed on the market, the EVO ICL was subject to extensive research and development. Today, more than 3,000,000 lenses have been distributed worldwide. In a survey, over 99.4 percent of patients would have the procedure again. The EVO ICL has a track record of excellent clinical outcomes. Additionally, the EVO ICL lens has been available internationally for over 10 years.

EVO ICL is intended to remain in place without maintenance. The lens can be removed by your eye care professional if needed in the future. If your physician removes the lens, you will lose the benefit of your vision correction.

No. EVO ICL is positioned behind the iris (the coloured part of the eye), where it is invisible to both you and others. Only your eye care practitioner will be able to tell that vision correction has taken place.

EVO ICL is not typically noticeable after it is implanted. It does not attach to any structures within the eye and does not move around once in place.

The EVO ICL surgery is performed on an outpatient basis which means that the patient has surgery and leaves the same day. The procedure itself usually takes 20-30 minutes or less. The patient will need someone to drive them home on surgery day. A light, topical or local anaesthetic is administered. There is very little discomfort during or after surgery. Some eye drops or medication may be prescribed and a visit with your eye care professional is usually scheduled the day after surgery.